E-LIB Suche - Ergebnisse für: Labopin, M

1

Allogeneic hematopoietic cell transplantation is equally ef..:

Sadowska-Klasa, A. ; Zaucha, J. M. ; Labopin, M....
Bone Marrow Transplantation. 59 (2024) 3 - p. 387-394 , 2024

Link: https://doi.org/10.1038/..

2

S238: MATCHED RELATED VERSUS UNRELATED VERSUS HAPLOIDENTICA..:

Nagler, A. ; Labopin, M. ; Mielke, S....
HemaSphere. 6 (2022) - p. 139-140 , 2022

Link: https://doi.org/10.1097/..

3

P1371: GRAFT-VERSUS-HOST DISEASE OFFERS NO GRAFT-VERSUS-LEU..:

Shimoni, A. ; Peczynski, C. ; Labopin, M....
HemaSphere. 6 (2022) - p. 1255-1256 , 2022

Link: https://doi.org/10.1097/..

4

P1355: VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDRO..:

Mohty, M. ; Yakoub-Agha, I. ; Dalle, J.-H....
HemaSphere. 6 (2022) - p. 1240-1241 , 2022

Link: https://doi.org/10.1097/..

5

Metabolic syndrome and cardiovascular disease after haemato..:

Greenfield, D. M. ; Salooja, N. ; Peczynski, C....
Bone Marrow Transplantation. 56 (2021) 11 - p. 2820-2825 , 2021

Link: https://doi.org/10.1038/..

6

DEFIBROTIDE TREATMENT IN PAEDIATRIC PATIENTS WITH SEVERE/VE..:

Gandemer, V. ; Schneider, P. ; Sirvent, A....
Hematology, Transfusion and Cell Therapy. 42 (2020) - p. 291-292 , 2020

Link: https://doi.org/10.1016/..

7

Postremission Consolidation by Autologous Hematopoietic Cel..:

Passweg, J.R. ; Labopin, M. ; Christopeit, M....
Biology of Blood and Marrow Transplantation. 26 (2020) 4 - p. 659-664 , 2020

Link: https://doi.org/10.1016/..

8

Impact of patient: donor HLA disparity on reduced-intensity..:

Loke, J. ; Labopin, M. ; Craddock, C....
Bone Marrow Transplantation. 56 (2020) 3 - p. 614-621 , 2020

Link: https://doi.org/10.1038/..

9

Hematopoietic cell transplant nurse coordinators' perceptio..:

Polomeni, A. ; Bompoint, C. ; Labopin, M....
Bone Marrow Transplantation. 55 (2019) 3 - p. 623-632 , 2019

Link: https://doi.org/10.1038/..

10

Cord blood transplantation is associated with good outcomes..:

Baron, F. ; Labopin, M. ; Ruggeri, A....
Journal of Internal Medicine. 285 (2019) 4 - p. 446-454 , 2019

Link: https://doi.org/10.1111/..

11

Trends in patient outcome over the past two decades followi..:

Canaani, J. ; Beohou, E. ; Labopin, M....
Journal of Internal Medicine. 285 (2018) 4 - p. 407-418 , 2018

Link: https://doi.org/10.1111/..

12

Prognostic factors for clinical response treated by allogen..:

Wen, L. ; Labopin, M. ; Badoglio, M....
Cytotherapy. 20 (2018) 5 - p. S57-S58 , 2018

Link: https://doi.org/10.1016/..

13

Distinct factors determine the kinetics of disease relapse ..:

Craddock, C. ; Versluis, J. ; Labopin, M....
Journal of Internal Medicine. 283 (2018) 4 - p. 371-379 , 2018

Link: https://doi.org/10.1111/..

14

OP021 Autologous haematopoietic stem cell transplantation f..:

Brierley, C ; Castilla-Llorente, C ; Labopin, M...
Journal of Crohn's and Colitis. 12 (2018) supplement_1 - p. S014-S015 , 2018

Link: https://doi.org/10.1093/..

15

REDUCED INTENSITY (FB2) VS REDUCED TOXICITY MYELOABLATIVE (..:

Le Bourgeois, A. ; Labopin, M. ; Blaise, D....
Hematological Oncology. 35 (2017) S2 - p. 193-194 , 2017

Link: https://doi.org/10.1002/..